tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany AnnouncementsKiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
1M ago
Kiniksa price target raised to $45 from $40 at Jefferies
Premium
The Fly
Kiniksa price target raised to $45 from $40 at Jefferies
1M ago
Kiniksa reports Q1 EPS 11c, consensus 28c
Premium
The Fly
Kiniksa reports Q1 EPS 11c, consensus 28c
1M ago
Kiniksa price target lowered to $30 from $35 at Wells Fargo
PremiumThe FlyKiniksa price target lowered to $30 from $35 at Wells Fargo
3M ago
Buy Rating for Kiniksa Pharmaceuticals Driven by Strategic Refocus and Commercial Success
Premium
Ratings
Buy Rating for Kiniksa Pharmaceuticals Driven by Strategic Refocus and Commercial Success
3M ago
Kiniksa Pharmaceuticals: Strategic Focus on Cardiovascular Growth and Stability Underpins Buy Rating
Premium
Ratings
Kiniksa Pharmaceuticals: Strategic Focus on Cardiovascular Growth and Stability Underpins Buy Rating
3M ago
Kiniksa announces development of KPL-387, updated corporate strategy
PremiumThe FlyKiniksa announces development of KPL-387, updated corporate strategy
3M ago
Kiniksa to discontinue development of abiprubart  in Sjogren’s Disease
Premium
The Fly
Kiniksa to discontinue development of abiprubart in Sjogren’s Disease
3M ago
Kiniksa Pharmaceuticals Ltd. Class A (KNSA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Kiniksa Pharmaceuticals Ltd. Class A (KNSA) Q4 Earnings Cheat Sheet
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100